STOCK TITAN

DOCS insider: Timothy Cabral converts, exercises options and completes 10b5-1 sales

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Insider transactions by Doximity director Timothy S. Cabral on 08/15/2025: Mr. Cabral converted 20,000 shares of Class B common stock into Class A shares and exercised 20,000 stock options with a $2.21 exercise price, resulting in 20,000 newly acquired Class A shares. He sold 16,200 Class A shares at a weighted-average price of approximately $63.682 and an additional 3,800 Class A shares at a weighted-average price of approximately $64.1889, under a Rule 10b5-1 trading plan adopted February 13, 2025. After these transactions he directly held 10,160 and 6,360 Class A shares as reported across sales; total Class B and exercised option conversions are noted as convertible to Class A.

Positive

  • Sales were executed under a Rule 10b5-1 trading plan, indicating pre-established, compliant disposition of shares
  • Options exercised at a low exercise price ($2.21), converting compensation into equity ownership
  • Disclosure includes weighted-average sale price ranges, allowing price transparency for investors

Negative

  • None.

Insights

TL;DR: Routine 10b5-1 sales and option exercise by a director; modest share sales at market prices, limited immediate governance impact.

The filing shows option exercise at a nominal exercise price and conversion of Class B to Class A shares, followed by sales executed under a pre-established Rule 10b5-1 plan. The sales volumes (20,000 total sold) and prices (~$63.16–$64.25 ranges) represent personal liquidity actions rather than corporate financing or dilutive events. No indication of special related-party transactions or unusual timing is present in the Form 4.

TL;DR: Transactions are standard insider activity under an approved trading plan; no governance red flags disclosed.

The report documents conversion rights of Class B to Class A shares and automatic conversion triggers, consistent with the issuer's charter. Sales occurred pursuant to an established 10b5-1 plan adopted February 13, 2025, and were handled by an attorney-in-fact signature, indicating routine administration. The filing does not show any restricted transfers or departures that would materially affect board composition or control.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cabral Timothy S

(Last) (First) (Middle)
C/O DOXIMITY, INC.
500 THIRD STREET

(Street)
SAN FRANCISCO CA 94107

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Doximity, Inc. [ DOCS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 08/15/2025 C(1) 20,000 A (1) 26,360 D
Class A Common Stock 08/15/2025 S(2) 16,200 D $63.682(3) 10,160 D
Class A Common Stock 08/15/2025 S(2) 3,800 D $64.1889(4) 6,360 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $2.21 08/15/2025 M 20,000 (5) 09/01/2030 Class B Common Stock(6) 20,000 $0 363,500 D
Class B Common Stock (6) 08/15/2025 M 20,000 (6) (6) Class A Common Stock 20,000 $0 20,000 D
Class B Common Stock (6) 08/15/2025 C(1) 20,000 (6) (6) Class A Common Stock 20,000 $0 0 D
Explanation of Responses:
1. Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder.
2. The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2025.
3. The price represents the weighted-average price of the shares sold in multiple transactions ranging from $63.1600 to $64.1400 per share, inclusive. The Reporting Person undertakes to provide the Issuer, a security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. The price represents the weighted-average price of the shares sold in multiple transactions ranging from $64.1600 to $64.2500 per share, inclusive. The Reporting Person undertakes to provide the Issuer, a security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. The stock option vested in 36 equal monthly installments after September 2, 2020, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. The stock option was granted on September 2, 2020.
6. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the Issuer's initial public offering; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class.
Remarks:
/s/ Jennifer Chaloemtiarana, Attorney-in-Fact 08/18/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Doximity director Timothy S. Cabral do on 08/15/2025 (DOCS)?

He converted 20,000 Class B shares to Class A, exercised 20,000 options at $2.21, and sold 20,000 Class A shares in total.

Were the share sales by Timothy Cabral planned or immediate trades?

The sales occurred automatically under a Rule 10b5-1 trading plan adopted on February 13, 2025.

At what prices were the shares sold in the Form 4?

Sales were at weighted-average prices of approximately $63.682 (range $63.16–$64.14) and $64.1889 (range $64.16–$64.25).

How many Class A shares did Cabral beneficially own after the transactions?

The Form 4 reports beneficial ownership figures of 10,160 and 6,360 Class A shares following the reported sales on separate reported lines.

Who signed the Form 4 filing for Timothy Cabral?

The Form 4 was signed by Jennifer Chaloemtiarana, Attorney-in-Fact on 08/18/2025.
Doximity Inc

NYSE:DOCS

View DOCS Stock Overview

DOCS Rankings

DOCS Latest News

DOCS Latest SEC Filings

DOCS Stock Data

4.51B
130.34M
Health Information Services
Services-computer Programming Services
Link
United States
SAN FRANCISCO